Radioterapi dengan Perlindungan Penglihatan pada Basal Cell Carcinoma Kelopak Mata

Rhandika Rafli, Fathiya Juwita Hanum

Abstract


Pendahuluan: Karsinoma sel basal merupakan kanker kulit yang sering terjadi pada wajah. Lesi pada kelopak mata merupakan daerah dengan resiko tinggi kekambuhan dan memiliki keterbatasan margin eksisi untuk mempertahankan fungsi kelopak mata. Laporan kasus: Laporan kasus ini menggambarkan penatalaksanaan yang dilakukan pada wanita 66 tahun yang ingin mempertahankan fungsi kelopak mata dan penglihatan. Operasi dilakukan dengan Mohs Micrografik yang dilanjutkan dengan radiasi adjuvan lokal dosis 50Gy dengan memperhatikan dosis constraint terhadap lensa dan retina. Pengawasan efek samping dilakukan selama radioterapi dan follow up efek samping kronis. Kesimpulan: Pasien dapat mempertahankan sebagian fungsi kelopak mata dan tidak mengalami gangguan penglihatan. Efek samping yang sering terjadi adalah dry eye syndrom yang memerlukan terapi air mata buatan.


Keywords


KSB, Radioterapi, kelopak mata

Full Text:

PDF

References


. Shi Y, Jia R, Fan X. Ocular basal cell carcinoma: A brief literature review of clinical diagnosis and treatment. Onco Targets Ther [Internet]. 2017 May 8 [cited 2022 Jan 7];10:2483–9. Available from: https://pubmed.ncbi.nlm.nih.gov/28507440/

. Yin VT, Merritt HA, Sniegowski M, Esmaeli B. Eyelid and ocular surface carcinoma: Diagnosis and management. Clin Dermatol [Internet]. 2015 Mar 1 [cited 2022 Jan 7];33(2):159–69. Available from: https://pubmed.ncbi.nlm.nih.gov/25704936/

. Furdova A, Kapitanova K, Kollarova A, Sekac J. Periocular basal cell carcinoma - Clinical perspectives [Internet]. Vol. 14, Oncology Reviews. Page Press Publications; 2020 [cited 2022 Jan 7]. p. 36–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32395200

. Hsu A, Frank SJ, Ballo MT, Garden AS, Morrison WH, Rosenthal DI, et al. Postoperative adjuvant external-beam radiation therapy for cancers of the eyelid and conjunctiva. Ophthal Plast Reconstr Surg. 2008 Nov;24(6):444–9.

. Dourmishev L, Rusinova D, Botev I. Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol Online J [Internet]. 2013 [cited 2022 Jan 7];4(1):12. Available from: /pmc/articles/PMC3573444/

. Smith H, Wernham A, Patel A. When to suspect a non-melanoma skin cancer. BMJ [Internet]. 2020 Mar 11 [cited 2022 Jan 7];368:m692. Available from: https://pubmed.ncbi.nlm.nih.gov/32161002/

. Casswell G, Cavanagh K, Ravi Kumar AS, Giddings C, McDowell L. Setting the stage: Contemporary staging of non-melanomatous skin cancer and implementation of the new American Joint Committee on cancer eighth edition staging manual. Oral Oncol [Internet]. 2019 Nov 1 [cited 2022 Jan 7];98:102–8. Available from: https://pubmed.ncbi.nlm.nih.gov/31574414/

. Bichakjian CK, Olencki T, Aasi SZ, Alam M, Andersen JS, Berg D, et al. Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw [Internet]. 2016 May 1 [cited 2022 Jan 7];14(5):574–97. Available from: https://pubmed.ncbi.nlm.nih.gov/27160235/

. Peris K, Fargnoli MC, Garbe C, Kaufmann R, Bastholt L, Seguin NB, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer [Internet]. 2019 Sep 1 [cited 2022 Jan 7];118:10–34. Available from: https://pubmed.ncbi.nlm.nih.gov/31288208/

. Kim DP, Kus KJB, Ruiz E. Basal Cell Carcinoma Review. Hematol Oncol Clin North Am [Internet]. 2019 Feb 1 [cited 2022 Jan 7];33(1):13–24. Available from: https://pubmed.ncbi.nlm.nih.gov/30497670/

. Frakulli R, Galuppi A, Cammelli S, Macchia G, Cima S, Gambacorta MA, et al. Brachytherapy in non melanoma skin cancer of eyelid: A systematic review [Internet]. Vol. 7, Journal of Contemporary Brachytherapy. J Contemp Brachytherapy; 2015 [cited 2022 Jan 7]. p. 497–502. Available from: https://pubmed.ncbi.nlm.nih.gov/26816508/

. Jeganathan VSE, Wirth A, MacManus MP. Ocular risks from orbital and periorbital radiation therapy: A critical review. Vol. 79, International Journal of Radiation Oncology Biology Physics. 2011. p. 650–9.

. Brodin NP, Tomé WA. Revisiting the dose constraints for head and neck OARs in the current era of IMRT. Oral Oncol [Internet]. 2018 Nov 1 [cited 2022 Jan 7];86:8–18. Available from: https://pubmed.ncbi.nlm.nih.gov/30409324/

. Astradsson A, Wiencke AK, Munck Af Rosenschold P, Engelholm SA, Ohlhues L, Roed H, et al. Visual outcome after fractionated stereotactic radiation therapy of benign anterior skull base tumors. J Neurooncol. 2014;118(1):101–8.

. RAFLI, Rhandyka., Anggraini D., Pitra DAH., et al. Radiotherapy Adverse Effects Management Training for Health Workers in Andalas University Hospital. Jurnal Kreativitas Pengabdian Kepada Masyarakat (Pkm), [S.l.], v. 5(7):2043-51, doi:https://doi.org/10.33024/jkpm.v5i7.6865




DOI: https://doi.org/10.33854/heme.v4i3.1039

DOI (PDF): https://doi.org/10.33854/heme.v4i3.1039.g439

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Health and Medical Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Creative Commons License   Health and Medical Journal This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.